SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 3 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $91 | +5.8% | 752 | 0.0% | 0.00% | +100.0% |
Q2 2023 | $86 | -17.3% | 752 | 0.0% | 0.00% | -50.0% |
Q1 2023 | $104 | +7.2% | 752 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $97 | -99.9% | 752 | 0.0% | 0.00% | +100.0% |
Q3 2022 | $83,000 | +48.2% | 752 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $56,000 | -5.1% | 752 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $59,000 | -13.2% | 752 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $68,000 | -2.9% | 752 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $70,000 | -10.3% | 752 | -24.8% | 0.00% | 0.0% |
Q2 2021 | $78,000 | +4.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $75,000 | -55.9% | 1,000 | 0.0% | 0.00% | -66.7% |
Q4 2020 | $170,000 | +21.4% | 1,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $140,000 | -12.5% | 1,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $160,000 | +63.3% | 1,000 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $98,000 | -24.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $129,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |